These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35508804)

  • 1. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
    Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
    Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma.
    Cao Z; Liu X; Zhang W; Zhang K; Pan L; Zhu M; Qin H; Zou C; Wang W; Zhang C; He Y; Lin W; Zhang Y; Han D; Li M; Gu J
    ACS Nano; 2023 Dec; 17(23):23746-23760. PubMed ID: 37991252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma Therapy Using Codelivery of Cisplatin and Glutathione Peroxidase Targeting siRNA from Iron Oxide Nanoparticles.
    Zhang Y; Fu X; Jia J; Wikerholmen T; Xi K; Kong Y; Wang J; Chen H; Ma Y; Li Z; Wang C; Qi Q; Thorsen F; Wang J; Cui J; Li X; Ni S
    ACS Appl Mater Interfaces; 2020 Sep; 12(39):43408-43421. PubMed ID: 32885649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
    Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
    Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
    Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX
    J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
    Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
    Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane-Decorated Exosomes for Combination Drug Delivery and Improved Glioma Therapy.
    Liang S; Xu H; Ye BC
    Langmuir; 2022 Jan; 38(1):299-308. PubMed ID: 34936368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
    Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
    J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
    Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
    Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
    Liang SF; Zuo FF; Yin BC; Ye BC
    Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy.
    Wang Y; Huo Y; Zhao C; Liu H; Shao Y; Zhu C; An L; Chen X; Chen Z
    J Control Release; 2024 Apr; 368():170-183. PubMed ID: 38382811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy.
    Chu L; Sun Y; Zhao Y; Wang A; Sun Y; Duan X; Li N; Xia H; Liu W; Sun K
    Int J Pharm; 2024 Jul; 660():124262. PubMed ID: 38815637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of exosomes as a new therapeutic strategy for glioblastoma.
    Cunha Silva L; Branco F; Cunha J; Vitorino C; Gomes C; Carrascal MA; Falcão A; Miguel Neves B; Teresa Cruz M
    Eur J Pharm Biopharm; 2024 Oct; 203():114460. PubMed ID: 39218361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
    Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
    Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
    Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
    AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near Infrared-Activatable Biomimetic Nanoplatform for Tumor-Specific Drug Release, Penetration and Chemo-Photothermal Synergistic Therapy of Orthotopic Glioblastoma.
    Li M; Zhang X; Zhou Y; Chu Y; Shen J; Cai Y; Sun X
    Int J Nanomedicine; 2024; 19():6999-7014. PubMed ID: 39011386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADPH Oxidase Subunit CYBB Confers Chemotherapy and Ferroptosis Resistance in Mesenchymal Glioblastoma via Nrf2/SOD2 Modulation.
    Su IC; Su YK; Setiawan SA; Yadav VK; Fong IH; Yeh CT; Lin CM; Liu HW
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG length effect of peptide-functional liposome for blood brain barrier (BBB) penetration and brain targeting.
    Du Q; Liu Y; Fan M; Wei S; Ismail M; Zheng M
    J Control Release; 2024 Aug; 372():85-94. PubMed ID: 38838784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.